We are pleased to announce that Laborie is investing in Novocuff, Inc. an early-stage medical technology that is developing a device to improve pregnancy outcomes and reduce preterm births. "We believe Novocuff's device has the potential to address pregnancy complications that often result in preterm birth, and our investment underscores our commitment to improving patient outcomes," said Nikki Bruce, Vice President and General Manager of Laborie's OB Business Unit. Read the press release: https://lnkd.in/eCnxG8qb #ForDignityForLife #Laborie
This is wonderful news !
Exciting technology. Great to see Laborie investing at an early stage and supporting Novocuff, Inc. in their commercialisation efforts!
Excited to follow the Novocuff journey!
So excited to see Laborie’s continued commitment to and investment in improving maternal health outcomes! Looking forward to a great partnership and future with Novocuff, Inc.
Fantastic news from Laborie OBGYN & Neonatal Health and Nikki Bruce for an investment in such a novel technology in women’s healthcare!
Congrats Laborie, Amelia, and Novocuff, Inc. Another good news story for the future of Maternal and infant health!
I am thrilled to be part of a company that prioritizes maternal health! Looking forward to the positive impact Novocuff, Inc. will bring for expecting mothers!
Changing the Standard of Skin-to-Skin Care, One Baby at a Time | Passionate Business Builder | Women’s Health Industry Expert
3moCongrats all around!